Cohort | Gender | Baseline | 4Â weeks post treatment | Reinfection assessment | |||||
---|---|---|---|---|---|---|---|---|---|
Positive children | No. of Screened | No. of attritions (%) | Cured children (%) | No. of Failure (%) | Screened children | Negative (%) | Reinfection Cases (%) | ||
A1 (28Â weeks) | Female | 49 | 36 | 13 (26.5) | 32 (88.9) | 4 (11.1) | 17 | 15 (88.2) | 2 (11.7) |
 | Male | 28 | 26 | 2 (7.1) | 22 (84.6) | 4 (15.3) | 8 | 8 (100.0) | 0 (0.0) |
A2 (20Â weeks) | Female | 24 | 14 | 10 (41.6) | 11 (78.57) | 3 (21.43) | 5 | 5 (100.0) | 0 (0.0) |
 | Male | 19 | 15 | 4 (21.0) | 12 (80.0) | 3 (20.0) | 7 | 6 (85.7) | 1 (14.3) |
 | Total | 120 | 91 | 29 (24.1) | 77 (84.6) | 14 (15.4) | 37 | 34 (91.9) | 3 (8.1%) |